▶ 調査レポート

世界のバイオセーフティ試験市場(~2028年):細胞株特性評価、ロットリリース試験、ウイルスクリアランス、その他

• 英文タイトル:Global Biosafety Testing Market Insights, Forecast to 2028

Global Biosafety Testing Market Insights, Forecast to 2028「世界のバイオセーフティ試験市場(~2028年):細胞株特性評価、ロットリリース試験、ウイルスクリアランス、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16733
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、バイオセーフティ試験のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
バイオセーフティ試験のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
バイオセーフティ試験の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
バイオセーフティ試験のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのバイオセーフティ試験の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のバイオセーフティ試験の売上および2028年までの予測に焦点を当てています。

バイオセーフティ試験のグローバル主要企業には、Merck、Charles River、Sartorius、Samsung Biologics、GenomeScan、Creative Biogene、Eurofins Scientific、Wuxi Biologics、Creative BioMart、SGS Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

バイオセーフティ試験市場は、タイプとアプリケーションによって区分されます。世界のバイオセーフティ試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
細胞株特性評価、ロットリリース試験、ウイルスクリアランス、その他

【アプリケーション別セグメント】
ワクチン、モノクローナル抗体、細胞治療、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- バイオセーフティ試験製品概要
- タイプ別市場(細胞株特性評価、ロットリリース試験、ウイルスクリアランス、その他)
- アプリケーション別市場(ワクチン、モノクローナル抗体、細胞治療、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のバイオセーフティ試験販売量予測2017-2028
- 世界のバイオセーフティ試験売上予測2017-2028
- バイオセーフティ試験の地域別販売量
- バイオセーフティ試験の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別バイオセーフティ試験販売量
- 主要メーカー別バイオセーフティ試験売上
- 主要メーカー別バイオセーフティ試験価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(細胞株特性評価、ロットリリース試験、ウイルスクリアランス、その他)
- バイオセーフティ試験のタイプ別販売量
- バイオセーフティ試験のタイプ別売上
- バイオセーフティ試験のタイプ別価格
・アプリケーション別市場規模(ワクチン、モノクローナル抗体、細胞治療、その他)
- バイオセーフティ試験のアプリケーション別販売量
- バイオセーフティ試験のアプリケーション別売上
- バイオセーフティ試験のアプリケーション別価格
・北米市場
- 北米のバイオセーフティ試験市場規模(タイプ別、アプリケーション別)
- 主要国別のバイオセーフティ試験市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのバイオセーフティ試験市場規模(タイプ別、アプリケーション別)
- 主要国別のバイオセーフティ試験市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のバイオセーフティ試験市場規模(タイプ別、アプリケーション別)
- 主要国別のバイオセーフティ試験市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のバイオセーフティ試験市場規模(タイプ別、アプリケーション別)
- 主要国別のバイオセーフティ試験市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのバイオセーフティ試験市場規模(タイプ別、アプリケーション別)
- 主要国別のバイオセーフティ試験市場規模(トルコ、サウジアラビア)
・企業情報
Merck、Charles River、Sartorius、Samsung Biologics、GenomeScan、Creative Biogene、Eurofins Scientific、Wuxi Biologics、Creative BioMart、SGS Group
・産業チェーン及び販売チャネル分析
- バイオセーフティ試験の産業チェーン分析
- バイオセーフティ試験の原材料
- バイオセーフティ試験の生産プロセス
- バイオセーフティ試験の販売及びマーケティング
- バイオセーフティ試験の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- バイオセーフティ試験の産業動向
- バイオセーフティ試験のマーケットドライバー
- バイオセーフティ試験の課題
- バイオセーフティ試験の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Biosafety Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Biosafety Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Biosafety Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Biosafety Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Biosafety Testing include Merck, Charles River, Sartorius, Samsung Biologics, GenomeScan, Creative Biogene, Eurofins Scientific, Wuxi Biologics and Creative BioMart, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biosafety Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Biosafety Testing market. Further, it explains the major drivers and regional dynamics of the global Biosafety Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck
Charles River
Sartorius
Samsung Biologics
GenomeScan
Creative Biogene
Eurofins Scientific
Wuxi Biologics
Creative BioMart
SGS Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Biosafety Testing Segment by Type
Cell Line Characterization
Lot Release Testing
Viral Clearance
Others
Biosafety Testing Segment by Application
Vaccine
Monoclonal Antibodies
Cell Therapy
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biosafety Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Biosafety Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Biosafety Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosafety Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosafety Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Biosafety Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Biosafety Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Charles River, Sartorius, Samsung Biologics, GenomeScan, Creative Biogene, Eurofins Scientific, Wuxi Biologics and Creative BioMart, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosafety Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosafety Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosafety Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosafety Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cell Line Characterization
1.2.3 Lot Release Testing
1.2.4 Viral Clearance
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biosafety Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Vaccine
1.3.3 Monoclonal Antibodies
1.3.4 Cell Therapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosafety Testing Market Perspective (2017-2028)
2.2 Biosafety Testing Growth Trends by Region
2.2.1 Biosafety Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosafety Testing Historic Market Size by Region (2017-2022)
2.2.3 Biosafety Testing Forecasted Market Size by Region (2023-2028)
2.3 Biosafety Testing Market Dynamics
2.3.1 Biosafety Testing Industry Trends
2.3.2 Biosafety Testing Market Drivers
2.3.3 Biosafety Testing Market Challenges
2.3.4 Biosafety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosafety Testing Players by Revenue
3.1.1 Global Top Biosafety Testing Players by Revenue (2017-2022)
3.1.2 Global Biosafety Testing Revenue Market Share by Players (2017-2022)
3.2 Global Biosafety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosafety Testing Revenue
3.4 Global Biosafety Testing Market Concentration Ratio
3.4.1 Global Biosafety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosafety Testing Revenue in 2021
3.5 Biosafety Testing Key Players Head office and Area Served
3.6 Key Players Biosafety Testing Product Solution and Service
3.7 Date of Enter into Biosafety Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosafety Testing Breakdown Data by Type
4.1 Global Biosafety Testing Historic Market Size by Type (2017-2022)
4.2 Global Biosafety Testing Forecasted Market Size by Type (2023-2028)
5 Biosafety Testing Breakdown Data by Application
5.1 Global Biosafety Testing Historic Market Size by Application (2017-2022)
5.2 Global Biosafety Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosafety Testing Market Size (2017-2028)
6.2 North America Biosafety Testing Market Size by Type
6.2.1 North America Biosafety Testing Market Size by Type (2017-2022)
6.2.2 North America Biosafety Testing Market Size by Type (2023-2028)
6.2.3 North America Biosafety Testing Market Share by Type (2017-2028)
6.3 North America Biosafety Testing Market Size by Application
6.3.1 North America Biosafety Testing Market Size by Application (2017-2022)
6.3.2 North America Biosafety Testing Market Size by Application (2023-2028)
6.3.3 North America Biosafety Testing Market Share by Application (2017-2028)
6.4 North America Biosafety Testing Market Size by Country
6.4.1 North America Biosafety Testing Market Size by Country (2017-2022)
6.4.2 North America Biosafety Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biosafety Testing Market Size (2017-2028)
7.2 Europe Biosafety Testing Market Size by Type
7.2.1 Europe Biosafety Testing Market Size by Type (2017-2022)
7.2.2 Europe Biosafety Testing Market Size by Type (2023-2028)
7.2.3 Europe Biosafety Testing Market Share by Type (2017-2028)
7.3 Europe Biosafety Testing Market Size by Application
7.3.1 Europe Biosafety Testing Market Size by Application (2017-2022)
7.3.2 Europe Biosafety Testing Market Size by Application (2023-2028)
7.3.3 Europe Biosafety Testing Market Share by Application (2017-2028)
7.4 Europe Biosafety Testing Market Size by Country
7.4.1 Europe Biosafety Testing Market Size by Country (2017-2022)
7.4.2 Europe Biosafety Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosafety Testing Market Size (2017-2028)
8.2 Asia-Pacific Biosafety Testing Market Size by Type
8.2.1 Asia-Pacific Biosafety Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biosafety Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biosafety Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Biosafety Testing Market Size by Application
8.3.1 Asia-Pacific Biosafety Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biosafety Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biosafety Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Biosafety Testing Market Size by Region
8.4.1 Asia-Pacific Biosafety Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biosafety Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosafety Testing Market Size (2017-2028)
9.2 Latin America Biosafety Testing Market Size by Type
9.2.1 Latin America Biosafety Testing Market Size by Type (2017-2022)
9.2.2 Latin America Biosafety Testing Market Size by Type (2023-2028)
9.2.3 Latin America Biosafety Testing Market Share by Type (2017-2028)
9.3 Latin America Biosafety Testing Market Size by Application
9.3.1 Latin America Biosafety Testing Market Size by Application (2017-2022)
9.3.2 Latin America Biosafety Testing Market Size by Application (2023-2028)
9.3.3 Latin America Biosafety Testing Market Share by Application (2017-2028)
9.4 Latin America Biosafety Testing Market Size by Country
9.4.1 Latin America Biosafety Testing Market Size by Country (2017-2022)
9.4.2 Latin America Biosafety Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosafety Testing Market Size (2017-2028)
10.2 Middle East & Africa Biosafety Testing Market Size by Type
10.2.1 Middle East & Africa Biosafety Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biosafety Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biosafety Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Biosafety Testing Market Size by Application
10.3.1 Middle East & Africa Biosafety Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biosafety Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biosafety Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Biosafety Testing Market Size by Country
10.4.1 Middle East & Africa Biosafety Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biosafety Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Biosafety Testing Introduction
11.1.4 Merck Revenue in Biosafety Testing Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Biosafety Testing Introduction
11.2.4 Charles River Revenue in Biosafety Testing Business (2017-2022)
11.2.5 Charles River Recent Developments
11.3 Sartorius
11.3.1 Sartorius Company Details
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Biosafety Testing Introduction
11.3.4 Sartorius Revenue in Biosafety Testing Business (2017-2022)
11.3.5 Sartorius Recent Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Biosafety Testing Introduction
11.4.4 Samsung Biologics Revenue in Biosafety Testing Business (2017-2022)
11.4.5 Samsung Biologics Recent Developments
11.5 GenomeScan
11.5.1 GenomeScan Company Details
11.5.2 GenomeScan Business Overview
11.5.3 GenomeScan Biosafety Testing Introduction
11.5.4 GenomeScan Revenue in Biosafety Testing Business (2017-2022)
11.5.5 GenomeScan Recent Developments
11.6 Creative Biogene
11.6.1 Creative Biogene Company Details
11.6.2 Creative Biogene Business Overview
11.6.3 Creative Biogene Biosafety Testing Introduction
11.6.4 Creative Biogene Revenue in Biosafety Testing Business (2017-2022)
11.6.5 Creative Biogene Recent Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Biosafety Testing Introduction
11.7.4 Eurofins Scientific Revenue in Biosafety Testing Business (2017-2022)
11.7.5 Eurofins Scientific Recent Developments
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Details
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics Biosafety Testing Introduction
11.8.4 Wuxi Biologics Revenue in Biosafety Testing Business (2017-2022)
11.8.5 Wuxi Biologics Recent Developments
11.9 Creative BioMart
11.9.1 Creative BioMart Company Details
11.9.2 Creative BioMart Business Overview
11.9.3 Creative BioMart Biosafety Testing Introduction
11.9.4 Creative BioMart Revenue in Biosafety Testing Business (2017-2022)
11.9.5 Creative BioMart Recent Developments
11.10 SGS Group
11.10.1 SGS Group Company Details
11.10.2 SGS Group Business Overview
11.10.3 SGS Group Biosafety Testing Introduction
11.10.4 SGS Group Revenue in Biosafety Testing Business (2017-2022)
11.10.5 SGS Group Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer